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Abstract Post-cardiac arrest myocardial dysfunction is a
common phenomenon after return of spontaneous circula-
tion (ROSC) and contributes to hemodynamic instability
and low survival rates after cardiac arrest. Mild hypother-
mia for 24 h after ROSC has been shown to signiﬁcantly
improve neurologic recovery and survival rates. In the
present study we investigate the inﬂuence of therapeutic
hypothermia on hemodynamic parameters in resuscitated
patients and on contractility in failing human myocardium.
We analyzed hemodynamic data from 200 cardiac arrest
survivors during the hypothermia period. The initial LVEF
was 32.6 ± 1.2% indicating a signiﬁcantly impaired LV
function. During hypothermia induction, the infusion rate
of epinephrine could be signiﬁcantly reduced from 9.1 ±
1.3 lg/min [arrival intensive care unit (ICU) 35.4C] to
4.6 ± 1.0 lg/min (34C) and 2.8 ± 0.5 lg/min (33C).
The dobutamine and norepinephrine application rates were
not changed signiﬁcantly. The mean arterial blood pressure
remained stable. The mean heart rate signiﬁcantly
decreased from 91.8 ± 1.7 bpm (arrival ICU) to 77.3 ±
1.5 bpm (34C) and 70.3 ± 1.4 bpm (33C). In vitro we
investigated the effect of hypothermia on isolated ven-
tricular muscle strips from explanted failing human hearts.
With decreasing temperature, the contractility increased to
a maximum of 168 ± 23% at 27C( n = 16, P\0.05).
Positive inotropic response to hypothermia was accompa-
nied by moderately increased rapid cooling contractures as
a measure of sarcoplasmic reticulum (SR) Ca
2? content,
but can be elicited even when the SR Ca
2? release is
blocked in the presence of ryanodine. Contraction and
relaxation kinetics are prolonged with hypothermia, indi-
cating increased Ca
2? sensitivity as the main mechanism
responsible for inotropy. In conclusion, mild hypothermia
stabilizes hemodynamics in cardiac arrest survivors which
might contribute to improved survival rates in these
patients. Mechanistically, we demonstrate that hypother-
mia improves contractility in failing human myocardium
most likely by increasing Ca
2?-sensitivity.
Keywords Hypothermia  Cardiac arrest  Resuscitation 
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Introduction
Survival after cardiac arrest remains low worldwide,
averaging B6% for out-of-hospital [1, 2] and 18% for
in-hospital arrest [1–3]. Even after return of spontaneous
circulation (ROSC) the overall prognosis is poor. The
National Registry of Cardiopulmonary Resuscitation
(NRCPR) reported in 2006 that among 19,819 adults who
regained ROSC, in-hospital mortality was 67% [4]. One
important contributor to the low survival rates after ROSC
is post-cardiac arrest myocardial dysfunction that is well
described in both animal and human studies [5–9]. Mild
hypothermia is the only therapy applied in the post-cardiac
arrest setting that has been shown to signiﬁcantly improve
survival rates [10, 11]. Therefore, international guidelines
recommend the induction of therapeutic hypothermia
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DOI 10.1007/s00392-010-0113-2(32–34C for 12–24 h) in all comatose survivors of cardiac
arrest [12, 13]. Several techniques are available to easily
and safely induce therapeutic hypothermia [10, 12, 14, 15].
By reducing oxygen consumption and numerous deleteri-
ous biochemical and physical mechanisms that lead to
reperfusion cell damage hypothermia reduces brain injury
and improves neurologic recovery [10, 15]. Moreover, in
several animal species [16–19] and nonfailing human
myocardium [16] hypothermia has been shown to directly
increase cardiac contractility. Contradictory, it has been
reported that hypothermia could decrease cardiac output
and increase the requirement of inotropics [15, 20].
In the present study, we systematically analyzed
hemodynamic parameters of cardiac arrest survivors during
the hypothermia period. Mechanistically, we investigated
the effects of hypothermia on contractility and Ca
2? han-
dling in isolated ventricular muscle strips from explanted
failing human hearts in vitro.
Methods
Clinical data analysis
We retrospectively analyzed the data from cardiac arrest
patients that were consecutively admitted to the Cardi-
ology Intensive Care Unit (ICU) of the University Heart
Center of Gottingen between January 2005 and December
2008 and treated with mild hypothermia (32–34C).
Patients were included when their records were avail-
able and all study relevant data were documented. 224
patients were screened. 24 patients were excluded
because of missing a signiﬁcant amount of data. Cardiac
arrest was deﬁned as being unconscious as a result of a
sudden pulseless collapse; ROSC was a return of a
spontaneous palpable pulse. Except for trauma, all causes
of cardiac arrest were considered [21–23]. Out-of-hos-
pital as well as in-hospital cardiac arrest patients were
included. Patients were eligible if they were 18 years and
older. All patients received intensive care interventions
as recommended by ILCOR [12, 13]. The trachea was
intubated and central venous access was established in
all patients. Invasive blood pressure, heart rate (HR) and
pulse oximetry data were monitored continuously. Core
temperature was measured continuously by a bladder
temperature probe (Foley catheter). Hemodynamic sup-
port with inotropic agents or vasopressors was used as
indicated to reach a mean arterial blood pressure (MAP)
of 80 mmHg. The dose of the different catecholamines
(epinephrine, norepinephrine and dobutamine) was
adjusted according to the clinical judgment of the phy-
sician on duty, considering MAP, HR, echocardiography
results, urine production and underlying disease. Invasive
measurements by pulmonary-artery catheter were per-
formed only in some patients, if the hemodynamic situ-
ation deteriorated over time.
If indicated, mechanical devices (intraaortic balloon
pump or microaxial LV-assist device [24–26]) were
implanted in the cath lab before the patients were trans-
ferred to the ICU. Arterial blood gas values were frequently
obtained to adjust the ventilator to maintain an arterial
oxygen saturation of 94–96% and a partial pressure of
arterial carbon dioxide (PaCO2) of 40 mmHg (corrected for
temperature). Left ventricular systolic function was asses-
sed by echocardiography in biplane standard views.
Hypothermia was induced in all patients that remained
unconscious after ROSC. After an initial evaluation of
neurological status, all patients received intravenous
sedation (midazolam or propofol and fentanyl or sufenta-
nil). To prevent shivering, paralysis was induced by
intravenous administration of pancuronium. All patients
were cooled with external cool packs and cold infusions,
starting right after arrival in the emergency room. In
addition, 38 patients received an intravascular cooling
catheter (CoolGuard
, Alsius) and 28 patients were placed
in a cooling tent (DeltaTherm
, KCI). Cooling catheter and
cooling tent were implemented when the patients arrived at
the ICU. Hypothermia induction was continued during
diagnostic or therapeutic procedures such as percutaneous
coronary intervention (PCI) or computed tomography (CT)
scan. The target temperature of 33C was maintained for
24 h while the patient continued to be sedated and para-
lyzed. After 24 h the patient was rewarmed passively and
cautiously (B0.25C/h). Sedation was stopped at a core
temperature of 35C.
We systematically reviewed the patients’ records with
respect to baseline characteristics, body core temperature,
hemodynamic parameters, hemodynamic interventions,
echocardiography results and timings of post-cardiac arrest
procedures. Since patients’ weight is often unknown in the
post-cardiac setting catecholamine doses are presented as
lg/min at certain time points.
In vitro experiments in isolated failing human
myocardium
Experiments were performed in ventricular myocardium
from human hearts obtained from patients with end-stage
heart failure undergoing heart transplantation. The study
protocol was reviewed and approved by the ethical
committee and were in accordance with institutional
guidelines. Preparation of muscle strips was performed as
described previously [27, 28]. Brieﬂy, immediately after
explantation of the hearts, the ventricles were stored in
cooled, modiﬁed Krebs-Henseleit buffer (KHB) that
contained (in mmol/L): Na
? 152, K
? 3.6, Cl
- 135,
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- 25, Mg
2? 0.6, H2PO4
- 1.3, SO4
2- 0.6, Ca
2? 2.5,
glucose 11.2, and insulin 10 IU/L. The KHB was con-
tinuously bubbled with carbogen (95% O2/5% CO2)t o
adjust the pH to 7.4. In addition, the KHB contained
30 mmol/L 2,3-butanedione monoxime (BDM) to protect
the myocardium during transportation and from injury as
a result of cutting at the time of muscle strip dissection
[29]. Thin ventricular trabeculae (diameter \0.6 mm)
were dissected with the help of a stereoscopic micro-
scope. All preparation steps were carried out in the
cardioprotective BDM solution. For the mechanical
measurements, the muscle strips were transferred to an
organ chamber and connected to the force gauge by
using ﬁne steel hooks (F30 type 372, Hugo Sachs
Elektronik). The muscle strips were submerged in the
modiﬁed KHB (composition given above) without BDM
at 37C. Isometric twitches were evoked by electrical
stimulation with a stimulation frequency of 1 Hz (stim-
ulation voltage 25% above threshold). The muscle strips
were initially pre-stretched with 1 mN and allowed to
equilibrate for 30 min. Thereafter, the muscle strips were
gradually stretched until maximum steady-state twitch
force was reached (Lmax). To investigate SR Ca
2? con-
tent, rapid cooling contractures (RCCs) were elicited at
steady-state conditions as previously described [27]. On
cooling from 37 to 1C, all Ca
2? from the SR is
released, which leads to a stable contracture of the
muscles, because all Ca
2? transport systems are blocked
by the low temperature. The amplitude of the contracture
reﬂects the SR Ca
2? content. Twitch force and RCCs
were measured at temperatures of 37, 35, 33, 31 and
27C under steady-state conditions at a stimulation fre-
quency of 1 Hz. It is important to note that RCCs are
contractures induced by an acute rapid temperature jump
to 1C and are used as a semiquantitative index of SR
Ca
2? availability. These RCCs should not be confused
with increase in stimulated twitch tension that is brought
by less dramatic changes in steady-state temperature
(37–27C).
To further investigate the role of the SR in the contri-
bution to the inotropic effect of hypothermia, we used a
protocol in which SR Ca
2? storage function was com-
pletely blocked by ryanodine (1 lmol/L) added to the
perfusate [17]. RCCs were again performed to check the
effectiveness of this protocol. Approximately 20 min after
application of ryanodine force stabilized on a new baseline
that was characterized by decreased developed force,
increased diastolic force, and prolonged twitch-timing. The
absence of any RCCs conﬁrmed a complete blockage of SR
Ca
2? handling. Hypothermia was applied again, and the
inotropic response was recorded under blocked SR Ca
2?
storage function. Due to the length of the experimental
protocols all experiments where run-down corrected for
each muscle strip and presented as percentage (%) of
change in force of contraction.
Statistical analysis
All values are presented as mean ± SEM. Differences
between values were evaluated for statistical signiﬁcance
by use of ANOVA followed by Tukey’s post test analysis.
Correlations were examined by linear regression analysis.
The signiﬁcance level was set at P\0.05.
The authors had full access to and take full responsi-
bility for the integrity of the data. All authors have read and
agreed to the manuscript as written.
Results
Baseline characteristics of the patients
We retrospectively analyzed the data of 200 consecutive
cardiac arrest patients between January 2005 and Decem-
ber 2008. The average age of the enrolled patients was
64.5 ± 1.0 years (range 18–100 years). 76% of the cases
were out-of hospital arrests. Most patients presented with
ventricular ﬁbrillation (53.5%) as the initial cardiac
rhythm; 34% of the patients had asystole, 9% PEA. The
predominant cause of cardiac arrest was acute myocardial
infarction (46.5%) followed by primary arrhythmias in
patients with ischemic heart disease (13.5%) or other car-
diomyopathies (14%). A signiﬁcantly reduced systolic left
ventricular function (LV) with an initial ejection fraction
(EF) of 32.6 ± 1.2% (range 10–65%) was documented by
echocardiography. In 75 patients (38%) an intraaortic
balloon pump was implanted. 6 patients (3%) received a
microaxial LV-assist device. In-hospital mortality was
45.5%. The detailed baseline characteristics are presented
in Table 1.
Cooling and hemodynamic data
The average time interval from admission to our hospital to
ICU arrival was 112.6 ± 10.0 min (Table 2). The main
reasons for this delay were procedures such as diagnostic
coronary angiography (59%), PCI (40%) or CT scans
(11%). Since cooling was started in the emergency room
(ER) and continued during the interventions such as PCI,
the initial core temperature (bladder temperature probe) on
ICU arrival was already 35.4 ± 0.1C. Body temperatures
of 34 and 33C were achieved 4.1 ± 0.3 and 7.1 ± 0.5 h
after admission to the ICU, respectively.
During induction of therapeutic hypothermia, the
hemodynamic support by epinephrine infusion could be
reduced from 9.1 ± 1.3 lg/min (arrival ICU) to 4.6 ±
Clin Res Cardiol (2010) 99:267–276 269
1231.0 lg/min (34C, P\0.05) and 2.8 ± 0.5 lg/min (33C,
P\0.05, Fig. 1a). At the same time, the application rate
of the vasoconstrictor norepinephrine did not signiﬁcantly
change (arrival ICU: 5.3 ± 1.0 lg/min, 34C: 7.1 ±
0.9 lg/min, 33C: 7.5 ± 0.9 lg/min, P = 0.16, Fig. 1b).
The infusion rate of dobutamine was not changed (arrival
ICU: 0.3 ± 0.1 mL/h; 34C: 0.4 ± 0.1 mL/h; 33C: 0.5 ±
0.1 mL/h; P = 0.23, Fig. 1c). Despite reduced epinephrine
dosage, the MAP remained stable at 82.7 ± 1.6 mmHg
(arrival ICU), 80.7 ± 1.2 mmHg (34C) and 78.4 ±
1.2 mmHg (33C, P = 0.09, Fig. 2a). The mean HR sig-
niﬁcantly decreased from 91.8 ± 1.7 bpm (arrival ICU) to
77.3 ± 1.5 bpm (34C, P\0.05) and 70.3 ± 1.4 bpm
(33C, P\0.05, Fig. 2b).
During the hypothermia maintenance period (24 h at
33C) the catecholamine dosages were not changed
signiﬁcantly (Fig. 1). During re-warming, the infusion
rate of norepinephrine slightly increased (P = 0.16),
whereas epinephrine and dobutamine remained stable
(Fig. 1).
Table 1 Baseline characteristics
Total no. of patients 200
Male sex, no. (%) 149 (74.5)
Female sex, no. (%) 51 (25.5)
Age, years 64.5 ± 1.0
Out-of-hospital arrest, no. (%) 151 (75.5)
Initial cardiac rhythm
Ventricular ﬁbrillation or tachycardia, no. (%) 107 (53.5)
Asystole, no. (%) 68 (34)
Pulseless electrical activity, no. (%) 18 (9)
Not reported, no. (%) 7 (3.5)
Diagnosis or cause of cardiac arrest
Myocardial infarction, no. (%) 93 (46.5)
Primary arrhythmia (CAD and reduced EF), no. (%) 27 (13.5)
Primary arrhythmia (other cardiomyopathy), no. (%) 28 (14)
Pulmonary embolism, no. (%) 9 (4.5)
Other, no. (%) 43 (21.5)
Initial LV ejection fraction, % 32.6 ± 1.2
no number, LV left ventricular, CAD coronary artery disease, EF
ejection fraction
Table 2 Cooling parameters
Time interval from ER admission to arrival ICU, min 112.6 ± 10.0
Reason for delay
Coronary angiography, no. (%) 118 (59)
Percutaneous coronary intervention (PCI), no. (%) 79 (40)
CT scan, no. (%) 22 (11)
Echocardiography, no. (%) 64 (32)
Initial body temperature at arrival ICU, C 35.4 ± 0.1
Time interval from arrival ICU to target temperature
To 34C, h 4.1 ± 0.3
To 33C, h 7.1 ± 0.5
ER emergency room, ICU intensive care unit, no number, CT com-
puter tomography
Fig. 1 Hemodynamic support by catecholamines during induction of
therapeutic hypothermia (on arrival at the intensive care unit (ICU), at
34 and 33C body temperature) and during the re-warming period
(after 24 h at 33C and after reaching 36.5C): a infusion rate of
epinephrine. *P\0.05 versus arrival ICU. b Infusion rate of
norepinephrine. c Infusion rate of dobutamine
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12340% of the patients were treated with PCI before they
were transferred to the ICU. To exclude the hemodynamic
effect of myocardial recovery due to PCI we analyzed the
data of all patients not treated with PCI. The results in this
subgroup did not differ from the whole study population
(Figs. 5, 6, online data supplement).
The efﬁcacy of catecholamines can be impaired by
acidosis. Therefore, we analyzed the arterial pH values
during hypothermia induction. At arrival to the ICU the pH
value was 7.30 ± 0.01, indicating a mild acidosis. With
hypothermia induction the pH increased to 7.39 ± 0.01 at
34C and 7.40 ± 0.01 at 33C( P\0.05 vs. arrival ICU,
Fig. 7, online data supplement).
Effect of hypothermia on contractility of isolated
failing human myocardium
Ventricular myocardium from human hearts was obtained
from 15 patients with end-stage failing dilated (n = 6) or
ischemic (n = 9) cardiomyopathy undergoing heart trans-
plantation. Mean age of the patients was 55.5 ± 2.2 years,
and mean EF was 23.5 ± 1.7%; 5 patients were women.
Detailed clinical data of these patients including medica-
tions are shown in Table 3 (online data supplement).
In failing human myocardium hypothermia induced a
temperature-dependent increase in force of contraction,
reaching statistical signiﬁcance at 33C and lower. Fig-
ure 3a demonstrates that a stepwise reduction in bath
temperature from 37 to 27C resulted in a maximal
increase in force of contraction to 167.5 ± 23.0%
(P\0.05 vs. 37C, n = 16).
To further elucidate the subcellular mechanism of the
inotropic effect of hypothermia, RCC experiments were
performed. By cooling the myocardium rapidly to 1C, all
SR Ca
2? is released leading to a stable contracture that is
indicative of the SR Ca
2? content. By step wisely lowering
the baseline temperature from 37 to 27C RCC amplitudes
increased to a maximum of 145.2 ± 8.4% at 27C
(P\0.05 vs. 37C, n = 16, Fig. 3b). This suggests that
hypothermia increases SR Ca
2? content in failing human
myocardium.
To further investigate the contribution of the SR to the
inotropic effects of hypothermia, SR function was inhibited
by ryanodine. Under SR blockade hypothermia still
increases contraction force amplitudes, reaching
145.1 ± 13.6% at 31C( P\0.05, n = 13, data not
shown). Interestingly, at 27C the contraction force
amplitude slightly decreased to 93.9 ± 17.0% (n = 13).
This is caused by a pronounced increase of the diastolic
force at 27C, exceeding the increase in systolic force
(Fig. 3c). However, in the temperature range from 37 to
31C the inotropic response to hypothermia was still
observed after blockade of SR function with ryanodine. A
linear regression analysis reveals that—excluding the 27C
values—there is a linear correlation between the contrac-
tion force with and without ryanodine (r = 0.75,
r
2 = 0.57, Fig. 3d) between 37 and 31C. This indicates
that the SR is not the main contributor to the positive
inotropic effect of hypothermia.
Figure 4 demonstrates the inﬂuence of hypothermia on
contraction and relaxation kinetics. The positive inotropic
effect of hypothermia is associated with a signiﬁcant
increase in time to peak tension (TTP), total twitch time
(TTT) and time to 50 and 90% relaxation (RT 50 and RT
90) typical for an increase in myoﬁlament Ca
2? sensitivity.
This prolongation in contraction and relaxation times was
even more pronounced in the presence of ryanodine.
Fig. 2 Hemodynamic parameters during induction of therapeutic
hypothermia (on arrival at the intensive care unit (ICU), at 34 and
33C body temperature) and re-warming (after 24 h at 33C and after
reaching 36.5C). a MAP mean arterial blood pressure. *P\0.05
versus arrival ICU, 34 and 33C. b HR heart rate. *P\0.05 versus
arrival ICU,
P\0.05 versus 34C,
#P\0.05 versus 34, 33 and
33C (24 h)
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The present study demonstrates that mild hypothermia
improves hemodynamics in cardiac arrest survivors. In
isolated failing human myocardium hypothermia signiﬁ-
cantly increases contractility. Positive inotropic response to
hypothermia is accompanied by moderately increased SR
Ca
2? content but can be elicited even when the SR Ca
2?
storage function is blocked. Contraction and relaxation
kinetics are prolonged with hypothermia, indicating
increased Ca
2? sensitivity of the myoﬁlaments as the main
mechanism for inotropy.
Hypothermic inotropism has been shown previously in
several animal studies [16–19]. In 1897, Langendorff [18]
was the ﬁrst to describe a relation between temperature and
myocardial function. Moreover, hypothermia has been
shown to increase contractility in nonfailing human myo-
cardium [16]. However, in the failing human heart, Ca
2?
cycling, contractile function and their response to external
interventions are signiﬁcantly altered compared to non-
failing hearts [27, 30, 31]. Intriguingly, we now demon-
strate that mild hypothermia improves contractility also in
failing human myocardium. Furthermore, in cardiac arrest
survivors presenting with impaired LV function, induction
of therapeutic hypothermia was associated with signiﬁ-
cantly reduced epinephrine requirement indicating hemo-
dynamic stabilization. Since the arterial pH increased from
7.30 (arrival ICU) to 7.39 (34C), it cannot be excluded
that the pH shift contributes to the reduced epinephrine
requirement. However, a pH of 7.30 indicates a very mild
acidosis and by reducing the body temperature from 34 to
33C the pH is not affected whereas the epinephrine dose
could be further reduced from 4.6 to 2.8 lg/min.
In the study of Bernard et al. [15] the cardiac index (CI)
decreased in hypothermia versus normothermia treated
cardiac arrest patients. However, systemic vascular
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Fig. 3 Effect of hypothermia
on contractility and Ca
2?
handling in isolated muscle
strips from failing human
myocardium. a Change in force
of contraction during stepwise
cooling from 37 to 27C.
Stimulation frequency: 1 Hz.
Average values from 16 muscle
strips given in percent of the
control value at 37C.
*P\0.05 versus control
(37C). b Inﬂuence of
temperature on rapid cooling
contractures (RCC). Changes in
the amplitude of RCCs upon
cooling are given in percent of
the control value at 37C.
Average values from 16 muscle
strips. *P\0.05 versus control
(37C). c Effect of ryanodine on
systolic and diastolic force
during mild hypothermia.
Average values from 13 muscle
strips. *P\0.05 versus control
(37C). d Correlation of change
in force of contraction during
hypothermia with and without
ryanodine. 27C values were
excluded since diastolic force
increased excessively at 27C.
Scatter plot with linear
regression analysis and 95%
conﬁdence interval. r = 0.75,
r
2 = 0.57
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123resistance (SVR) was signiﬁcantly increased in these
patients, which might explain the reduced cardiac output.
In pigs mild hypothermia increased CI without signiﬁ-
cantly affecting SVR [16]. Higher incidence of required
epinephrine infusions in the study of Bernard et al. [15]
includes the rewarming period and does therefore not argue
against our results.
To elucidate the subcellular effects of mild hypo-
thermia, we performed RCC measurements in muscle
strips from failing human myocardium. In contrast to
previous data from pig myocardium [16], mild hypo-
thermia moderately increased RCC amplitudes indicating
that SR Ca
2? content may be increased. One could
speculate that increased SR Ca
2? load may be associated
with subsequent enhanced SR Ca
2? release. However,
the inotropic response to hypothermia was still observed
after complete blockade of SR function with ryanodine.
This ﬁnding is in line with experimental data from
Shattock and Bers [17], indicating that mechanisms,
other than those involving the SR, contribute to the
hypothermia-induced inotropism. One possibility is
increased Ca
2? sensitivity. In the present study, hypo-
thermia prolonged both contraction and relaxation times,
indicating increased Ca
2? responsiveness of the myoﬁl-
aments as an important underlying mechanism of posi-
tive inotropism [32]. Increased Ca
2? sensitivity might
result from hypothermia-induced alkalosis [33, 34]o r
slowed cross-bridge cycling rate [35].
While systolic performance is clearly improved at all
temperature steps investigated, increasing myoﬁlament
Ca
2? sensitivity might induce diastolic dysfunction [36].
In the present study, we observed an increase in diastolic
force at 27C particularly when SR function was inhib-
ited by ryanodine, indicating that pronounced hypother-
mia might impair diastolic function. This has important
implications for the treatment of successfully resuscitated
patients, since diastolic dysfunction is a common phe-
nomenon after ROSC [37–40]. However, in the temper-
ature range recommended for therapeutic hypothermia in
cardiac arrest patients (32–34C) [12, 13], we did not
observe any relevant changes in diastolic function. Fur-
thermore, our clinical data demonstrate that hypothermia
signiﬁcantly reduces HR, an intervention that usually
improves LV ﬁlling [41]. However, since optimal cool-
ing temperature is still under investigation, it should
be considered that temperatures below the current
Fig. 4 Inﬂuence of
hypothermia on contraction and
relaxation kinetics. Average
values from 13 muscle strips
with and 16 muscle strips
without ryanodine (Rya).
Stimulation frequency: 1 Hz.
*P\0.05 versus control
(37C).
#P\0.05 with
ryanodine versus without
ryanodine (37C). a Time to
peak tension (TTP), b total
twitch time (TTT), c time to
50% relaxation (RT 50), d time
to 90% relaxation (RT 90)
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123recommendations might induce or worsen diastolic heart
failure.
Post-cardiac arrest myocardial dysfunction is responsive
to inotropic drugs [39, 42]. In swine, dobutamine infusions
of 5–10 lg(kg min) substantially improve systolic and
diastolic function after cardiac arrest [39]. However, cAMP
dependent inotropes such as b-adreno-agonists or phos-
phodiesterase III inhibitors, increase myocardial oxygen
consumption, can exacerbate or induce ischemia in patients
with coronary artery disease, can exert direct cardiac tox-
icity and have consistently been proven to increase mor-
tality in chronic heart failure [43–45]. As discussed above,
hypothermia most likely acts by sensitizing the myoﬁla-
ments for Ca
2?. In contrast to cAMP elevating inotropes,
hypothermia prolongs contraction and relaxation times,
acts partially independently of SR function and signiﬁ-
cantly reduces HR. Therefore, it may favorably impact
myocardial energetics relative to traditional inotropic
therapies. Animal studies have shown that in myocardial
infarction hypothermia decreases oxygen consumption and
infarct size [46, 47]. Preliminary data indicate that mild
hypothermia might represent an attractive approach to
increase contractility not only after cardiac arrest but also
in other patients with cardiogenic shock [48].
Our clinical data demonstrate that hypothermia signiﬁ-
cantly reduces HR. In this context, it is important to note
that the force-frequency relation is inversed during hypo-
thermia. Lewis et al. [49] have nicely shown that higher
HRs result in reduced contractility at colder temperatures.
Therefore, lower HRs are beneﬁcial during hypothermia.
This study has some limitations. Due to the hemody-
namic stabilization during hypothermia induction, invasive
hemodynamic measurements by pulmonary catheter were
not performed routinely. Therefore, invasive hemodynamic
data cannot be provided.
There was no normothermia control group of resusci-
tated patients with which to compare changes in hemody-
namic parameters. Since post-cardiac arrest myocardial
dysfunction is a potentially reversible phenomenon [6, 7,
50], we cannot completely exclude that hemodynamic
stabilization might occur independently of hypothermia
induction. However, Bernard et al. [15] described no
increase of CI values in the normothermia group during the
ﬁrst 6 h after admission to the ICU. Moreover, it has been
reported that CI values reach their nadir at 8 h after
resuscitation [6]. In contrast, we observed a signiﬁcant
reduction in epinephrine requirement within 6 h, indicating
an accelerated improvement of hemodynamics by induc-
tion of hypothermia. Furthermore, our in vitro experiments
were performed in a control-matched setting, demonstrat-
ing that hypothermia instantly increases contractility in one
and the same failing myocardial muscle strip.
During the re-warming period, the catecholamine
doses were not changed signiﬁcantly. However, the re-
warming period could not be compared with the cooling
induction for several reasons: (1) as mentioned above,
post-cardiac arrest myocardial dysfunction reaches its
nadir 8 h after ROSC. Contractility is known to recover
after 24 h [6]. Therefore, it is not surprising that the
requirement for epinephrine and dobutamine did not rise
again. (2) As recommended [12], hypothermia was
induced as rapid as possible, whereas re-warming was
performed very slowly (0.2C/h). A body temperature of
36.5C was reached after 18.7 h (almost 3 times slower
than cooling induction). This is a long time for com-
pensatory mechanisms. (3) Induction and maintenance of
therapeutic hypothermia were performed under constantly
deep sedation. During the re-warming period sedation
was stopped after reaching 35C. Increasing vigilance
will likely interfere with the need for catecholamines. (4)
Normothermia was reached approximately 48 h after
ROSC. At this time point many of the ventilated cardiac
arrest patients are affected by infections and sepsis that
will inﬂuence the hemodynamic situation.
Hemodynamic instability as part of the post-cardiac
arrest syndrome is not only caused by myocardial dys-
function, but also a severe systemic ischemia/reperfusion
response, having many characteristics in common with
sepsis, i.e. systemic inﬂammation, endothelial activation,
impaired vasoregulation and intravascular volume deple-
tion [12, 51–54]. In the present study, we demonstrate that
mild hypothermia increases contractility in failing human
myocardium. This effect most likely contributes to the
early hemodynamic stabilization we observed in cardiac
arrest survivors treated with hypothermia. However, since
hypothermia has been reported to increase SVR [15], this
might also help to stabilize the hemodynamic situation in
the post-cardiac arrest syndrome. In our study population
the application rate of the vasopressor norepinephrine was
slightly but not signiﬁcantly increased during hypothermia
induction and re-warming.
In conclusion, mild hypothermia stabilizes hemody-
namics in cardiac arrest survivors, which might contribute
to improved survival rates in these patients. As one pos-
sible mechanism we demonstrate that hypothermia
increases contractility in the failing human myocardium
most likely by increasing Ca
2? sensitivity. Further studies
are required to evaluate hypothermia as inotropic inter-
vention in patients with cardiogenic shock.
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